论文部分内容阅读
目的观察注射用还原型谷胱甘肽联合通心络胶囊、参麦注射液治疗间质性肺疾病的临床疗效。方法选择呼吸科间质性肺疾病与肺纤维化患者48例,随机分为治疗组和对照组各24例,对照组给予常规糖皮质激素、通心络胶囊及参麦注射液治疗,治疗组在对照组基础上给予注射用还原型谷胱甘肽治疗,比较2组治疗效果。结果治疗组总有效率为87.5%高于对照组的62.5%,差异有统计学意义(P<0.05)。结论注射用还原型谷胱甘肽联合通心络胶囊、参麦注射液治疗间质性肺疾病效果显著,值得临床借鉴。
Objective To observe the clinical efficacy of injectable glutathione combined with Tongxinluo capsule and Shenmai injection in the treatment of interstitial lung disease. Methods Forty-eight patients with pulmonary interstitial lung disease and pulmonary fibrosis were selected and randomly divided into treatment group (24 cases) and control group (24 cases). The control group was given conventional glucocorticoid, Tongxinluo capsule and Shenmai injection. The treatment group On the basis of the control group given for injection of reduced glutathione treatment, the treatment effect of two groups were compared. Results The total effective rate of the treatment group was 87.5% higher than that of the control group (62.5%), the difference was statistically significant (P <0.05). Conclusion Injection of glutathione combined with Tongxinluo capsule, Shenmai injection of interstitial lung disease treatment effect is significant, it is worth learning from.